4--hydroxychalcone and Hyperlipidemias

4--hydroxychalcone has been researched along with Hyperlipidemias* in 1 studies

Other Studies

1 other study(ies) available for 4--hydroxychalcone and Hyperlipidemias

ArticleYear
Synthesis and in-vivo hypolipidemic activity of some novel substituted phenyl isoxazol phenoxy acetic acid derivatives.
    Bioorganic & medicinal chemistry letters, 2014, May-01, Volume: 24, Issue:9

    The present study was undertaken to evaluate in-vivo hypolipidemic activity of a novel series of 2-methyl-2-(substituted phenyl isoxazol)phenoxyacetic acid derivatives by triton induced hyperlipidemia in rats. The newly synthesized compounds 5a, 5d and 5g showed significant decrease in the serum TCH, TG, LDL and VLDL along with an increase in serum HDL levels as compared to standard drug Fenofibrate. The treated groups also showed significant decrease in the atherogenic index and increase in % protective activity compared to control group.

    Topics: Acetates; Androstenols; Animals; Female; Hyperlipidemias; Hypolipidemic Agents; Lipids; Male; Rats; Rats, Wistar

2014